Xiaoyu Li
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Bone Metabolism and Diseases 4
- Oncology 17
- Cancer Immunotherapy and Biomarkers 5
- Bone health and treatments 4
- Co-authors
- Namrata D. Udeshi (1 shared paper)Peter Grauman (1 shared paper)Christie Ciarlo (1 shared paper)Tanya Svinkina (1 shared paper)Benjamin L. Ebert (1 shared paper)Marie McConkey (1 shared paper)Nikhil C. Munshi (1 shared paper)Monica Schenone (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)RSC Advances (3 papers)Journal of Clinical Oncology (3 papers)Biochemical and Biophysical Research Communications (2 papers)Journal of Biotechnology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaoyu Li
85 papers receiving 3.1k citations
Xiaoyu Li's Hit Papers
Peers
Comparison fields: 5 of 144
- Hematology 578
- Oncology 645
- Molecular Biology 1.5k
- Organic Chemistry 474
- Cancer Research 215
Countries citing papers authored by Xiaoyu Li
This map shows the geographic impact of Xiaoyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu Li more than expected).
Fields of papers citing papers by Xiaoyu Li
This network shows the impact of papers produced by Xiaoyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu Li. The network helps show where Xiaoyu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoyu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells Hit paper breakdown → | 2013 | 1331 |
| 2 | 2015 | 125 | |
| 3 | 2015 | 105 | |
| 4 | 2012 | 78 | |
| 5 | 2013 | 77 | |
| 6 | 2011 | 73 | |
| 7 | 2009 | 73 | |
| 8 | 2014 | 65 | |
| 9 | 2019 | 64 | |
| 10 | 2017 | 60 | |
| 11 | 2015 | 57 | |
| 12 | 2010 | 56 | |
| 13 | 2008 | 54 | |
| 14 | 2009 | 50 | |
| 15 | 2013 | 47 | |
| 16 | 2011 | 46 | |
| 17 | 2016 | 39 | |
| 18 | 2009 | 38 | |
| 19 | 2014 | 34 | |
| 20 | 2020 | 34 |
About Xiaoyu Li
Xiaoyu Li is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hematology and Cancer Research, having authored 93 papers that have together received 3.2k indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (5 papers), Catalytic Cross-Coupling Reactions (5 papers), Catalytic C–H Functionalization Methods (5 papers), Bone Metabolism and Diseases (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Bone health and treatments (4 papers). The work is most often cited by research in Hematology (578 citations), Oncology (645 citations), Molecular Biology (1.5k citations), Organic Chemistry (474 citations) and Cancer Research (215 citations). Xiaoyu Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Namrata D. Udeshi, Peter Grauman, Christie Ciarlo, Tanya Svinkina, Benjamin L. Ebert, Marie McConkey, Nikhil C. Munshi, Monica Schenone, Stuart L. Schreiber and Dirk Heckl. Their work appears in journals such as Frontiers in Oncology, RSC Advances, Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Journal of Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.